Recalls affecting Mississippi
Notices that name Mississippi in their distribution area, plus every nationwide recall — nationwide recalls reach Mississippi too.
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 112 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 25 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Ascend Laboratories, LLC Amlodipine and Olmesartan Medoxomil Tablets, 10 mg/20 mg recall: Failed Dissolution Specifications; Olmesartan Medoxomil content below
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
-
Class II · 3 months ago
Bionpharma Inc. Divalproex Sodium Delayed-Release Tablets, USP, 500 mg recall: Presence of Foreign Tablets/Capsules
Presence of Foreign Tablets/Capsules
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Max Strength , Sterile, Twin Pack recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Lidocaine HCl Injection, USP, 2%, 100 mg per 5 mL recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 50 mcg recall: Subpotent Drug
Subpotent Drug
-
Class III · 3 months ago
Ascend Laboratories, LLC Dabigatran etexilate Capsules, 150 mg, 20-count carton recall: Failed Impurities/Degradation Specifications: OOS result was observed during
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II…
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Dry Aid , Sterile, 0.34 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Xylocaine , 1%, 200 mg per 20 mL , 25 Multiple-Dose Vials recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Digi Eye , Sterile, 0.4 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 25 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 125 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 75 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Fresenius Kabi USA, LLC Naropin , 0.5%, 100 mg per 20 mL , Twenty-five recall: Presence of Particulate Matter: Hair was found in products
Presence of Particulate Matter: Hair was found in products
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 88 mcg recall: Subpotent Drug
Subpotent Drug
-
Class III · 3 months ago
Supernus Pharmaceuticals, Inc. Trokendi XR, topiramate extended-release capsules recall: Failed Dissolution Specifications
Failed Dissolution Specifications
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 150 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Cool Relief , Sterile recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 3 months ago
Major Pharmaceuticals Levothyroxine Sodium Tablets, USP, 75 mcg recall: Subpotent Drug
Subpotent Drug
-
Class II · 3 months ago
Rohto-Mentholatum Co., Ltd. Rohto Cooling Eye Drops Max Strength , Sterile 0.4 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class I · 3 months ago
Total Nutrition Inc 1. TNVitamins 100% Organic Moringa Capsules 1 recall: Contaminated with Salmonella
Contaminated with Salmonella
-
Class I · 3 months ago
Modern Warrior Ready, Dietary Supplement, 60 Capsules recall: FDA analysis revealed the presence of unapproved ingredients including
FDA analysis revealed the presence of unapproved ingredients including tianeptine, 1,4 DMAA, and aniracetam.
-
NHTSA safety recall · 3 months ago
Mercedes-Benz recall: Please refer to MBUSA's recall report for specific model information
Please refer to MBUSA's recall report for specific model information. The micro-switch in the driver's door lock may corrode and fail to detect an…